Skip to main content
Philip Levin, MD, Endocrinology, Baltimore, MD

PhilipALevinMD

Endocrinology Baltimore, MD

Diabetes, Lipid Metabolism

Physician

Dr. Levin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Levin's full profile

Already have an account?

  • Office

    6535 N Charles St
    Ste 400
    Baltimore, MD 21204
    Phone+1 410-828-7417
    Fax+1 410-828-4695

Education & Training

  • Ohio State University Hospital
    Ohio State University HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 1978 - 1980
  • MedStar Health/Georgetown University Hospital
    MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 1977 - 1978
  • St Mary's Hospital (Waterbury)
    St Mary's Hospital (Waterbury)Residency, Internal Medicine, 1975 - 1977
  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterInternship, Transitional Year, 1974 - 1975
  • University of Maryland School of Medicine
    University of Maryland School of MedicineClass of 1974

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1975 - 2026
  • OH State Medical License
    OH State Medical License 1979 - 1982
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • MannKind Presents Novel Scientific Data at 13th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2020)
    MannKind Presents Novel Scientific Data at 13th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2020)February 20th, 2020
  • MannKind Presents Positive Afrezza® Clinical Data from Three Studies at ADA 79th Scientific Sessions
    MannKind Presents Positive Afrezza® Clinical Data from Three Studies at ADA 79th Scientific SessionsJune 9th, 2019
  • Digital Health Start-up Amalgam Rx Launches with Insulin Titration App
    Digital Health Start-up Amalgam Rx Launches with Insulin Titration AppMay 1st, 2017

Professional Memberships